Janiel M. Shields

3.2k total citations · 1 hit paper
31 papers, 2.6k citations indexed

About

Janiel M. Shields is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Janiel M. Shields has authored 31 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Janiel M. Shields's work include Melanoma and MAPK Pathways (10 papers), Kruppel-like factors research (6 papers) and DNA Repair Mechanisms (4 papers). Janiel M. Shields is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Kruppel-like factors research (6 papers) and DNA Repair Mechanisms (4 papers). Janiel M. Shields collaborates with scholars based in United States, Germany and Japan. Janiel M. Shields's co-authors include Vincent W. Yang, Robert J. Christy, Channing J. Der, Weiqing Zhang, Klaus H. Kaestner, Kelley Rogers-Graham, Nancy E. Thomas, Randall J. Kimple, Maria J. Sambade and William K. Kaufmann and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Janiel M. Shields

31 papers receiving 2.6k citations

Hit Papers

Identification and Characterization of a Gene Encoding a ... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janiel M. Shields United States 23 2.0k 549 535 348 194 31 2.6k
Joëlle Roche France 32 2.5k 1.2× 281 0.5× 752 1.4× 394 1.1× 119 0.6× 59 3.1k
Radha P. Narsimhan United States 16 1.9k 0.9× 181 0.3× 646 1.2× 305 0.9× 277 1.4× 20 3.1k
Ricardo Sánchez‐Prieto Spain 26 1.3k 0.7× 252 0.5× 696 1.3× 374 1.1× 153 0.8× 74 2.1k
Suhad Ali Canada 30 1.5k 0.7× 293 0.5× 1.1k 2.0× 334 1.0× 370 1.9× 58 2.4k
Hugh Arnold United States 15 2.0k 1.0× 210 0.4× 797 1.5× 398 1.1× 214 1.1× 18 2.7k
Rónán C. O’Hagan United States 18 2.2k 1.1× 327 0.6× 1.1k 2.1× 458 1.3× 322 1.7× 30 3.1k
Theresa LaVallee United States 22 1.4k 0.7× 420 0.8× 722 1.3× 745 2.1× 306 1.6× 57 2.4k
Zhiliang Jia United States 35 2.3k 1.1× 315 0.6× 916 1.7× 802 2.3× 287 1.5× 46 3.1k
Bruce W. Konicek United States 20 1.8k 0.9× 203 0.4× 447 0.8× 344 1.0× 234 1.2× 37 2.3k
Nancy Olashaw United States 26 2.0k 1.0× 178 0.3× 645 1.2× 370 1.1× 347 1.8× 39 2.9k

Countries citing papers authored by Janiel M. Shields

Since Specialization
Citations

This map shows the geographic impact of Janiel M. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janiel M. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janiel M. Shields more than expected).

Fields of papers citing papers by Janiel M. Shields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janiel M. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janiel M. Shields. The network helps show where Janiel M. Shields may publish in the future.

Co-authorship network of co-authors of Janiel M. Shields

This figure shows the co-authorship network connecting the top 25 collaborators of Janiel M. Shields. A scholar is included among the top collaborators of Janiel M. Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janiel M. Shields. Janiel M. Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunleavey, James M., Lin Xiao, Joshua J. Thompson, et al.. (2014). Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nature Communications. 5(1). 5200–5200. 58 indexed citations
2.
Kimple, Randall J., Janet K. Horton, Chad Livasy, et al.. (2012). Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer. The Oncologist. 17(12). 1496–1503. 12 indexed citations
3.
Carson, Craig C., Bernard Omolo, Haitao Chu, et al.. (2012). A prognostic signature of defective p53‐dependent G1 checkpoint function in melanoma cell lines. Pigment Cell & Melanoma Research. 25(4). 514–526. 16 indexed citations
4.
Sambade, Maria J., Eldon C. Peters, Nancy E. Thomas, et al.. (2011). Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiotherapy and Oncology. 98(3). 394–399. 101 indexed citations
5.
Gaddameedhi, Shobhan, Michael G. Kemp, Joyce T. Reardon, et al.. (2010). Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells. Cancer Research. 70(12). 4922–4930. 50 indexed citations
6.
Sambade, Maria J., Randall J. Kimple, Eldon C. Peters, et al.. (2010). Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts. International Journal of Radiation Oncology*Biology*Physics. 77(2). 575–581. 38 indexed citations
7.
Kimple, Randall J., Angelina V. Vaseva, Adrienne D. Cox, et al.. (2010). Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status. Clinical Cancer Research. 16(3). 912–923. 53 indexed citations
9.
Shields, Janiel M., Nancy E. Thomas, Melissa A. Cregger, et al.. (2007). Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma. Cancer Research. 67(4). 1502–1512. 66 indexed citations
10.
Kaufmann, William K., Kathleen R. Nevis, Pingping Qu, et al.. (2007). Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression. Journal of Investigative Dermatology. 128(1). 175–187. 52 indexed citations
11.
Rozenberg, Gabriela I., Daniel C. Zedek, Pamela A. Groben, et al.. (2007). CD200 is induced by ERK and is a potential therapeutic target in melanoma. Journal of Clinical Investigation. 117(12). 3922–9. 94 indexed citations
12.
Baines, Antonio T., Kian‐Huat Lim, Janiel M. Shields, et al.. (2006). Use of Retrovirus Expression of Interfering RNA to Determine the Contribution of Activated K‐Ras and Ras Effector Expression to Human Tumor Cell Growth. Methods in enzymology on CD-ROM/Methods in enzymology. 407. 556–574. 19 indexed citations
13.
Pruitt, Kevin, Aylin S. Ülkü, Rafael J. Rojas, et al.. (2005). Ras-mediated Loss of the Pro-apoptotic Response Protein Par-4 Is Mediated by DNA Hypermethylation through Raf-independent and Raf-dependent Signaling Cascades in Epithelial Cells. Journal of Biological Chemistry. 280(24). 23363–23370. 75 indexed citations
14.
Shields, Janiel M., Channing J. Der, Colby A. Wyatt, et al.. (2004). Overexpression of Collagenase 1 (MMP-1) Is Mediated by the ERK Pathway in Invasive Melanoma Cells. Journal of Biological Chemistry. 279(32). 33168–33176. 124 indexed citations
15.
Shields, Janiel M., et al.. (2002). Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin. Molecular and Cellular Biology. 22(7). 2304–2317. 56 indexed citations
16.
Shields, Janiel M., Kelley Rogers-Graham, & Channing J. Der. (2002). Loss of Transgelin in Breast and Colon Tumors and in RIE-1 Cells by Ras Deregulation of Gene Expression through Raf-independent Pathways. Journal of Biological Chemistry. 277(12). 9790–9799. 122 indexed citations
17.
Zhang, Weiqing, Janiel M. Shields, Kazuhiro Sogawa, Yoshiaki Fujii‐Kuriyama, & Vincent W. Yang. (1998). The Gut-enriched Krüppel-like Factor Suppresses the Activity of the CYP1A1 Promoter in an Sp1-dependent Fashion. Journal of Biological Chemistry. 273(28). 17917–17925. 110 indexed citations
18.
Tonthat, H, et al.. (1997). Expression of the gut‐enriched Krüppel‐like factor gene during development and intestinal tumorigenesis. FEBS Letters. 419(2-3). 239–243. 92 indexed citations
19.
Shields, Janiel M. & Vincent W. Yang. (1997). Two Potent Nuclear Localization Signals in the Gut-enriched Krüppel-like Factor Define a Subfamily of Closely Related Krüppel Proteins. Journal of Biological Chemistry. 272(29). 18504–18507. 116 indexed citations
20.
Shields, Janiel M., Robert J. Christy, & Vincent W. Yang. (1996). Identification and Characterization of a Gene Encoding a Gut-enriched Krüppel-like Factor Expressed during Growth Arrest. Journal of Biological Chemistry. 271(33). 20009–20017. 552 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026